Home > Healthcare > Medical Devices > Therapeutic Devices > Nebulizers Market

Nebulizers Market - By Product (Jet Nebulizer {Vented, Breath Actuated}, Ultrasonic Nebulizer, Mesh Nebulizer, Nebulizer Accessories), By Portability (Portable/Handheld, Tabletop), By End-use (Medical, Homecare) & Global Forecast, 2023 – 2032

  • Report ID: GMI3452
  • Published Date: Mar 2023
  • Report Format: PDF

Nebulizers Market Size

Nebulizers Market size was worth more than USD 783 million in 2022 and is estimated to record significant growth at around 9.5% CAGR from 2023 to 2032 driven by the rising prevalence of respiratory diseases globally.
 

Nebulizers Market

To understand key trends  

Respiratory ailments have been spreading increasingly owing to the high level of air pollution. Moreover, smoking and occupational exposures cause airway blockage, which leads to COPD. Nebulizers help to ensure that the proper medicine is delivered to the right location in the respiratory system. Research has indicated that using nebulizers can improve outcomes for conditions, including seasonal flu brought on by weather changes, chronic obstructive pulmonary disease (COPD), bronchitis, and even asthma. The National Institute for Health Statistics estimates that 25 million Americans suffer from asthma.
 

Prolonged drug delivery time to limit product uptake

Customers have considerable issues with traditional nebulizers because of their size, long treatment duration, and power needs, which is hindering the nebulizers market expansion. Drug delivery with nebulizers is a time-consuming process that results in significant medication loss while constantly operating nebulizers. Nebulizers have persistently low lung delivery efficiency and need lengthy delivery periods for high-dose drugs. The airflow rate that powers the nebulizer affects how long it takes to deliver the drug.
 

Nebulizers Market Analysis

Nebulizers Market Share, By Product

To understand key trends  

In terms of product, the jet nebulizers market is anticipated to reach over USD 1.2 billion by 2032. Emphysema, lower respiratory infections, and pulmonary hypertension are among the various respiratory diseases that affect the elderly population. Nebulizers and other inhaled medication therapy are necessary for the treatment of such morbidities. Jet nebulizers are inexpensive and require minimal effort from the patient to produce an aerosol, which is a major factor driving product demand. 

 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for nebulizers was valued at over USD 783 million in 2022 and is projected to grow significantly at around 9.5% CAGR between 2023 and 2032 propelled by the rising prevalence of respiratory diseases globally.
Tabletop segment is estimated to surpass a valuation of USD 1 billion by the end of 2032 driven by the availability of reimbursement policies.
North America nebulizers market accounted for more than 38% of the overall industry revenue in 2022 and is expected to grow rapidly through 2032 owing to the high cases of respiratory disorders and chronic diseases in the region.
Sunset Healthcare Solutions, Omron Corporation, PARI Respiratory Equipment, Inc., Allied Healthcare Products, Inc., Koninklijke Philips N.V., VYAIRE MEDICAL, INC., Vectura Group Ltd, Lepu Medical Technology (Beijing) Co. Ltd., and GF Health Products, Inc., are some of the prominent enterprises engaged in the nebulizers industry.

Nebulizers Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 577
  • Countries covered: 25
  • Pages: 310
 Download PDF
Call Us  Download PDF